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Abstract (max 150 words, unstructured) 
High dietary glycemic index (GI) and glycemic load (GL) may increase cancer risk. 
However, limited information was available on GI and/or GL and head and neck cancer 
(HNC) risk. We conducted a pooled analysis on 8 case-control studies (4,081 HNC cases; 
7,407 controls) from the International Head and Neck Cancer Epidemiology (INHANCE) 
consortium. We estimated the odds ratios (ORs) and 95% confidence intervals (CIs) of 
HNC, and its subsites, from fixed- or mixed-effects logistic models including center-
specific quartiles of GI or GL. GI, but not GL, had a weak positive association with HNC 
(ORQ4 vs. Q1=1.16; 95% CI= 1.02-1.31). In sub-sites, we found a positive association 
between GI and laryngeal cancer (ORQ4 vs. Q1=1.60; 95% CI= 1.30-1.96) and an inverse 
association between GL and oropharyngeal cancer (ORQ4 vs. Q1=0.78; 95% CI= 0.63-0.97). 
This pooled analysis indicates a modest positive association between GI and HNC, 
mainly driven by laryngeal cancer. 
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BACKGROUND 
Most head and neck cancers (HNCs) are attributed to tobacco smoking and/or alcohol 
drinking.1 Diet has been suggested to play a role in HNC etiology, with non-starchy 
vegetables and selected healthy dietary patterns being inversely related with HNC risk. 2 
2 2 
Average daily glycemic index (GI) ranks carbohydrate foods based on the postprandial 
blood glucose response; average glycemic load (GL) estimates the impact of 
carbohydrate consumption using the GI, while taking into account the amount of 
carbohydrates that are consumed.3 Higher GI and GL are moderately associated with risk 
of several cancers4, likely because of stimulation of insulin release and bioactivity of 
insulin-like growth factor-1, which has proliferative, angiogenic, anti-apoptotic, and 
estrogen stimulating properties.5 
Only two studies6,7 have investigated the effect of GI and GL on HNC risk, with 
inconsistent findings; one of these studies6 reported results by sub-site, based, however, 
on a limited number of cases. 
The objective of this paper is to assess the association of GI or GL with HNC and its 
subsites (i.e., oral cavity, oropharynx, hypopharynx, and larynx) using pooled dietary data 
from eight case-control studies participating in the International Head and Neck Cancer 
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Epidemiology (INHANCE) consortium.8 
 
METHODS 
Within data version 1.5 of the INHANCE dataset, information on GI and GL was available 
from 3 case-control studies. In addition, we calculated GI and/or GL intakes from study-
specific food items and food composition databases for another 5 studies, giving a total 
of 8 studies included in the analysis. Details on individual studies and data pooling 
methods have been previously described8 and are summarized in Supplementary Table 
S1. Informed consents and institutional review board approvals were obtained within the 
framework of the original studies. 
Selection of subjects 
Cases were included if their cancer had been originally classified as invasive cancer of 
the oral cavity, pharynx, larynx, or unspecified oral cavity/pharynx. Corresponding 
controls from the original studies were included in the analysis. We excluded subjects 
with missing information on the site of origin of cancer, or GI or GL value, and those with 
missing or implausible (<500 or >5,500 kcal/day) non-alcohol energy intake. Thus, our 
analysis included 11,488 subjects, with 4,081 HNC cases and 7,407 controls (4,264 
hospital-based and 3,143 population-based controls). There were 810 oral cavity, 1,172 
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oropharynx, 343 hypopharynx, 1,338 larynx, and 418 unspecified oral cavity/pharynx 
cancer cases. 
Specification of variables 
Study-specific food-frequency questionnaires (FFQs) and food composition tables 
allowed us to calculate individual values of GI and GL for the 4 studies lacking information 
on both the exposures [Los Angeles, Boston, Seattle (1985-1995) and Memorial Sloan 
Kettering Cancer Center (MSKCC) studies]. In detail, as described previously9, the GI of 
a food was expressed as a percentage of the glycemic response elicited by white bread 
as a standard food with a GI of 100. The average daily GI for each subject was computed 
by summing the products of the GI value of each food times the amount of available 
carbohydrates in that food consumed per day, divided by the total amount of available 
carbohydrates (g) consumed per day. The average daily GL (g) was calculated by 
summing the products of the GI value of each food times the amount of available 
carbohydrates in that food consumed per day, divided by 100. Each GL unit represents 
the equivalent of 1 g of carbohydrate from white bread. Therefore, we preliminary 
converted frequencies of consumption into servings/day and servings/day into grams/day; 
then, we assigned the corresponding GI to each food item and applied the previous 
formulas to derived individual GI and GL values. For the North Carolina (2002-2006) study, 
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information on individual values of GL was originally provided to the INHANCE 
Consortium Coordinating Center. We estimated GI as 100 multiplied with GL and divided 
by total available grams of carbohydrate intake (Supplementary Material – text and 
Table S2 for GI/GL calculation and study-specific GI values). 
Statistical analysis 
Multiple logistic regression models were used to estimate the odds ratios (ORs) of HNC 
and the corresponding 95% confidence intervals (CIs) according to center-specific 
quartiles of GI or GL among controls (Supplementary Tables S3 for descriptive statistics 
of GI and GL distributions). In the presence of heterogeneity of GI or GL intakes across 
centers, we used a random-slope logistic regression model, whereas a fixed-effects 
model was used otherwise.10 The models included the following potential confounders: 
age, sex, race/ethnicity, study center, education, cigarette smoking intensity, cigarette 
smoking duration, cigar smoking status, pipe smoking status, alcohol drinking intensity, 
and the product term of cigarette smoking and alcohol drinking intensities. For GI, models 
were further adjusted for energy intake without alcohol; for GL, models were further 
adjusted for energy intake without alcohol and carbohydrates. For both GI and GL models, 
we used center-specific control-based quartiles of energy intake. Separate analyses were 
carried out by HNC sub-sites and in strata of selected covariates. In sensitivity analyses, 
 8 
we further adjusted for history of diabetes or excluded subjects with diabetes (information 
available for 6 studies). Analyses were performed using the SAS software (version 9.4, 
SAS Institute, Cary, NC). 
 
RESULTS 
Characteristics of our sample were presented in Supplementary Table S4. The highest 
GI quartile category (Q4) was associated with a higher HNC risk (ORQ4 vs. Q1=1.16; 95% 
CI= 1.02-1.31, ptrend=0.037, Table 1). Across HNC sub-sites, GI was associated with an 
increased laryngeal cancer risk (ORQ4 vs. Q1=1.60; 95% CI= 1.30-1.96, ptrend<0.001), but 
excluding laryngeal cancer cases, the ORQ4 vs. Q1 was 1.01 (95% CI= 0.88-1.16, 
ptrend=0.90) (data not shown). Little associations between GL and cancers of the oral 
cavity, hypopharynx, and larynx were observed. An inverse association was found 
between oropharyngeal cancer risk and GL (ORQ4 vs. Q1=0.78; 95% CI= 0.63-0.97, 
ptrend=0.009). Results did not materially change when excluding subjects with diabetes or 
when additionally adjusting models by diabetes history. No heterogeneity was observed 
in strata of covariates (Supplementary Table S5). 
 
DISCUSSION 
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In this large dataset, we observed a positive association between GI and HNC risk, 
essentially driven by laryngeal cancer. GL was not associated with the risk of overall HNC 
or its sub-sites, except for a possible inverse association with oropharyngeal cancer. 
Inconsistent associations of GI and GL with HNC risk may be partly due to differences in 
the underlying dietary patterns. Indeed, higher dietary GL is strongly associated with 
higher carbohydrate intakes, while a higher GI is also associated with lower intakes of 
dairy products, legumes, fruit and vegetables.11 In line with this hypothesis, an 
overlapping INHANCE-based analysis including 7 of the 8 current studies showed a 
positive association of laryngeal cancer with an “Animal products and cereals” dietary 
pattern, which was simultaneously based on high-GI (e.g. cereals) and low-GL (e.g. meat) 
foods.10 
Only two previous studies6,7 have examined the association between GI or GL and HNC 
risk, with one of them partially overlapping with the current dataset.6 An analysis6 of three 
Italian case-control studies on upper aero-digestive tract cancers reported a positive 
association with higher GI (ORQ5 vs. Q1=1.5; 95% CI=1.1-2.0) and GL (ORQ5 vs. Q1=1.8; 95% 
CI=1.1-2.9) in quintiles. Although in the same direction, the association was weaker with 
oral and pharyngeal cancers combined or laryngeal cancer.6 Findings from the National 
Institutes of Health–AARP Diet and Health Study (1,239 HNC cases; 446,177 participants) 
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reported a null association with GI and a possible inverse association with GL in women 
(ORQ5 vs. Q1=0.63; 95% CI=0.34-1.19), in the absence of a clear dose-response 
relationship.7 
Limitations of the current analyses included possible recall bias and non-differential 
misclassification of GI/GL quartiles. In addition, food items contributing to GI differed in 
part across regions (Supplementary Table S2). However, all our FFQs were either 
reproducible and valid or were modifications of existing FFQs, already tested for 
reproducibility and validity. We were able to adjust for major potential confounders and 
our large sample size provided the necessary statistical power to examine the association 
in HNC sub-sites and strata.8 
In conclusion, findings from this large-scale pooled analysis support a positive effect of 
average daily GI on the risk of HNC, and in particular of laryngeal cancer.  
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Table 1. Odds ratios (ORs)a and 95% confidence intervals (CIs) of glycemic index and glycemic load on cancers of head and 
neck, oral cavity, oropharynx, hypopharynx, and larynx. International Head and Neck Cancer Epidemiology (INHANCE) 
consortium. 
  
Head and neck cancer 
(No. cases=3,967, No. 
controls=7,250b) 
Oral cavity cancer 
(No. cases =780, 
No. 
controls=7,250b) 
Oropharyngeal cancer 
(No. cases=1,151, No. 
controls=7,250b) 
Hypopharyngeal cancer 
(No. cases =328, No. 
controls=6,866b) 
Laryngeal cancer 
(No. cases =11,299, No. 
controls=6,443b) 
  OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Glycemic Index      
    I Quartile Reference Reference Reference Reference Reference 
    II Quartile 1.04 (0.91, 1.18) 0.92 (0.70, 1.20) 0.93 (0.77, 1.13) 0.87 (0.61, 1.23) 1.33 (1.08, 1.65) 
    III Quartile 1.02 (0.90, 1.17) 1.08 (0.66, 1.75) 0.90 (0.74, 1.09) 0.95 (0.68, 1.35) 1.28 (1.04, 1.59) 
    IV Quartile 1.16 (1.02, 1.31) 1.21 (0.81, 1.81) 0.93 (0.76, 1.12) 0.84 (0.59, 1.20) 1.60 (1.30, 1.96) 
    Pfor linear trend 0.037 0.63 0.40 0.46 <0.001 
    Pheterogeneityc,d 0.35 0.03 0.41 0.22 0.66 
Glycemic Load      
    I Quartile Reference Reference Reference Reference Reference 
    II Quartile 0.94 (0.82, 1.07) 0.88 (0.70, 1.12) 0.91 (0.75, 1.11) 0.78 (0.54, 1.13) 0.95 (0.76, 1.18) 
    III Quartile 0.89 (0.78, 1.02) 0.86 (0.68, 1.10) 0.75 (0.61, 0.92) 0.74 (0.51, 1.09) 1.03 (0.83, 1.28) 
    IV Quartile 0.91 (0.79, 1.05) 0.89 (0.69, 1.15) 0.78 (0.63, 0.97) 0.84 (0.57, 1.22) 1.03 (0.82, 1.28) 
    Pfor linear trend 0.15 0.37 0.009 0.41 0.63 
    Pheterogeneityc,d 0.52 0.30 0.97 0.24 0.68 
a. Models adjusted for age, sex, race/ethnicity, study center, education level, center-specific control-based quartiles of energy intake (without alcohol for 
glycemic index; without alcohol and carbohydrate for glycemic load), cigarette smoking intensity (number of cigarettes per day), cigarette smoking duration, 
cigar smoking status, pipe smoking status, alcohol drinking intensity (number of drinks per day), and the product (interaction) term for cigarette smoking 
intensity and alcohol drinking intensity. b. The number of controls differed across sub-sites because a few studies considered cancers of the oral cavity, 
oropharynx, and hypopharynx only; therefore, they contributed to the analysis with fewer controls than those studies with all cancer sub-sites included (see 
Supplementary Table 4).  c. P-value for heterogeneity between study centers. d. Based on the likelihood ratio test of heterogeneity between study centers, we 
reported the fixed-effects estimates when Pheterogeneity > 0.1 and the mixed-effects estimates when Pstudies < 0.1.  
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METHODS (extended) 
Glycemic index and glycemic load checking 
Information on individual values of glycemic index (GI) and glycemic load (GL) was 
originally provided to the International Head and Neck Cancer Epidemiology 
(INHANCE) Consortium Coordinating Center by the Principal Investigators of the 
Italy Multicenter, Switzerland, and Milan (2006-2009) studies. Calculation of GI and 
GL was based on the same (reproducible and valid) food-frequency questionnaire 
(FFQ) and food-composition tables1 across the three studies. An extended 
description was provided in full elsewhere.2 For those studies, we checked missing 
or inconsistent values and solved inconsistencies, when possible. 
Glycemic index and glycemic load estimation 
GI and GL were estimated for Los Angeles, Boston, Seattle (1985-1995) and 
Memorial Sloan Kettering Cancer Center (MSKCC) studies from their FFQs by the 
following steps: 
1. Converting the consumption frequency to servings per day 
For Boston and Seattle (1985-1995) studies, a daily serving for each food item was 
obtained by DIETSYS Nutrient Analysis System. For the Los Angeles study, daily 
serving was calculated by using consumption frequency times the weight of none, 
daily, weekly, monthly and yearly consumption frequency (0, 1, 1/7, 1/30.42 and 
1/365, respectively). For the MSCKK study, the raw data from INHANCE consortium 
only contained the information of frequency per month instead of daily, weekly, 
monthly and yearly consumption frequency. Hence, a daily serving was calculated by: 
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(monthly frequency/30.42) * the serving size. The weights for small, medium and 
large serving size were 0.5, 1 and 1.25, respectively.   
2. Converting daily serving to daily intake in gram 
Grams per portion size for each food item were obtained from the U.S. Department 
of Agriculture (USDA).3 USDA Nutrient Database Standard Reference, version 16 
(SR16)4 provides the grams per portion size as well as the nutritional composition for 
each food item. Daily intake (gram) was calculated by multiplying the daily serving of 
specific food item by its grams per portion size. Available carbohydrate per 100 
grams for each food item was also obtained from the same source. We defined 
available carbohydrate to be the USDA-based value for grams of carbohydrate per 
100 grams minus the USDA value for grams of dietary fiber per 100 grams. Daily 
available carbohydrate intake (g/day) was calculated by summing the products of 
available carbohydrate (g/100g) of the specific food item by daily intakes (g) and 
dividing by 100. 
3. Assigned glycemic index value to each food item 
We linked GI values (using a scale assuming bread=100) to each food item using 
the published GI estimates. We searched for the most similar food item within the 
international GI tables5,6, considering only studies in healthy subjects and conducted 
in the United States or Canada. Whenever more than one GI value was provided for 
the same type of food in the international table, the average GI value was assigned 
to that food item. When the food item could not be found in the tables, we then 
searched the GI values compiled by Flood et al..7 The process of linkage was carried 
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out by manual reviewing the GI tables to identify the best matches for each food item 
in the questionnaire. 
4. Daily glycemic index and glycemic load calculation  
Average dietary GI and GL were calculated by the following formula3,8,9:  
!"#$%&#	()#*%$+	,- =
∑(12		34	5678	4339	:;5<	∗	6>6:?6@?5	AB6<C	34	76B@38D9B6;5	:E;6F5	34	5678	4339	:;5<);3;6?	6>6:?6@?5	AB6<C	34	76B@38D9B6;5	:E;6F5	   
H%)I+	,J = ∑(12		34	5678	4339	:;5<	∗	6>6:?6@?5	AB6<C	34	76B@38D9B6;5	:E;6F5	34	5678	4339	:;5<)KLL            
where the sum was carried out across all foods consumed by each subject. Each GL 
unit represents the effect of consuming one gram of carbohydrate from bread. 
For the North Carolina (2002-2006) study, information on individual values of daily 
GL was originally provided to the INHANCE Consortium Coordinating Center by the 
Principal Investigators. We estimated dietary GI as 100 multiplied with GL divided by 
total available grams of carbohydrate intake. 
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Supplementary Tables 
  
Supplementary Table 1. Characteristics of individual studies in the International Head and Neck Cancer Epidemiology (INHANCE) 
Consortium used in the current analysis. 
Study 
Reference 
paper 
Recruitment 
period 
 
Source (cases/ 
controls) 
Participation 
rate, % 
(cases/controls) 
Age 
eligibility 
(years) 
Number of 
subjects (cases/ 
controls) 
Questionnaire, 
administration, reference 
period for the recall, 
reproducibility and validity 
Frequency Serving 
sizea 
# Food items (including 
non-alcoholic 
beverages) 
Italy 
Multicenter 
Bosetti et al., 
2003b 
1990-1999 Hospital/Hospital-
unhealthy 
>95/>95 18-80 1261/2716 FFQ, interviewer- 
administered, 2 year 
before disease, 
reproducible and valid 
Raw data S/M/L 78 (including 6 non-
alcoholic beverages) 
Switzerland 
Levi et al., 
1998b 
1991-1997 Hospital/Hospital-
unhealthy 
>95/>95 <80 516/883 FFQ, interviewer-
administered, 2 year 
before disease, 
reproducible and valid 
Raw data S/M/L 78 (including 6 non-
alcoholic beverages) 
Los Angeles, 
CA, USA  Cui 
et al., 2006 
1999-2004 Cancer registry/ 
Neighborhood 
49/68 18-65 417/1005 FFQ, interviewer-
administered, during the 
past year, modification of 
an existing FFQ, tested 
for reproducibility and 
validity 
Raw data M 78 (including 11 non-
alcoholic beverages) 
Boston, MA, 
USA    Peters 
et al., 2005 
1999-2004 Hospital/ 
Residential 
records 
88.7/48.7 ≥18 584/659 FFQ, self-administered, 
during the past year, 
reproducible and valid 
Categories M 138 (including 12 non-
alcoholic beverages) 
New York, 
MSKCC, USA 
Schantz et al., 
1997 
1992-1994 Hospital/Blood 
donors 
NA NA 134/169 FFQ–diet history, self-
administered, during the 
past year, modification of 
an existing FFQ, tested 
for reproducibility and 
validity c 
Raw data S/M/L 88 (including 5 non-
alcoholic beverages)  
Milan (2006-
2009), Italy 
Bravi et al., 
2013 b 
2006-2009 Hospital/Hospital-
unhealthy 
>95/>95 18-80 367/750 FFQ, interviewer- 
administered, 2 years 
before disease, 
reproducible and valid 
Raw data S/M/L 78 (including 6 non-
alcoholic beverages) 
North 
Carolina 
(2002-2006), 
USA 
Divaris et al., 
2010c 
2002-2006 Cancer registry/ 
DMV files 
82/61 20-80 1368/1396 FFQ, interviewer-
administered, during the 
past year, modification of 
an existing FFQ, tested 
for reproducibility and 
validity 
Categories M 72 (including 5 non-
alcoholic beverages) 
questions 
Seattle (1985-
1995), WA, 
USA 
Rosenblatt et 
al, 2004 d 
1985-1995 Cancer registry/ 
Random digit 
dialing 
54.4/63.3; 
63.0/60.9 
18-65 407/607 FFQ, interviewer-
administered, 5 years 
ago, reproducible and 
valid 
Raw data S/M/L 106 (including 7 non-
alcoholic beverages) 
  6 
ABBREVIATIONS: DMV: Department of Motor Vehicles; FFQ: food-frequency questionnaire; S: small; M: medium; MSKCC: Memorial Sloan Kettering Cancer Center; L: large; NA: not 
available. 
a. A quantification of the medium serving size was provided in all the studies. b. Italy Multicenter, Milan (2006-2009) and Switzerland studies were based on the same food-frequency 
questionnaire. c. The food-frequency questionnaire from the North Carolina study provided combined questions concerning consumption of specific food items and corresponding 
condiment habits or fat content of the food item of interest (i.e. while asking for cooked or raw vegetable consumption, the food frequency questionnaire asked for extra information on 
fat, sauce, or dressing added after cooking or at the table). d. Two response rates are reported because data were collected in two population-based case-control studies, the first from 
1985 to 1989 among men and the second from 1990 to 1995 among men and women. 
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Supplementary Table 2. Glycemic index values for selected food items in the food frequency questionnaires included in the current analysis. 
International Head and Neck Cancer Epidemiology (INHANCE) consortium. 
Boston and North Carolina (2002-2006)a Los Angeles MSKCC and Seattlea Italy Multicenter, Switzerland, and Milan (2006 - 2009)a 
Food item GI GI x CHOb Food item GI GI x CHOb Food item GI GI x CHOb Food item GI GI x CHOb  
Potatoes-
bake/boil/mash 
158 3865 Other white potatoes 
(boiled, baked, potato 
salad, mashed) 
159 3762 Other potatoes, yams 158 1932 Maize (polenta) 106 4325 
Pretzels 119 2564 Other cold cereals such as 
Corn Flakes, Rice Krispies 
114 2847 Other cold cereals 114 2840 Bread 101 3232 
Cold breakfast cereal 114 2136 Corn bread, corn muffins, 
corn tortillas 
108 2920 Watermelon (in season) 109 592 Biscuits 95 4057 
Pancakes/wafflesc 110 5578 White bread (including 
sandwiches), bagels, etc. 
104 6075 Other soups 108 1721 Fruit or jam pies 93 6092 
Chowder/cream soup 108 1721 Watermelon (in season) 103 1118 Corn bread, corn muffins, 
corn tortillas 
108 2924 Sugar 89 262 
Regular muffins/biscuits 107 3327 Rice 103 3985 White bread, rolls, crackers 
(include sandwiches) 
105 4198 Pizza 86 6321 
Doughnuts 107 2682 Cantaloupe (in season) 93 1079 Rice 103 3389 Risotto 86 6125 
White bread, including 
pita 
105 2099 French fries, fried 
potatoes, hash browns 
91 2764 Other fruit juices, fortified 
fruit drinks 
97 2324 Ice cream 83 1718 
Jam/jelly/syrup/honey 104 1404 Regular soft drinks (not 
diet) 
90 6298 Hamburgers, 
cheeseburgers, meat loaf 
94 3000 Lasagne, 
tortellini with 
meat filling 
64 3611 
White rice 103 4519 Beef stew or pot pie with 
vegetables 
89 1093 Cantaloupe (in season) 93 299 Pasta/rice with 
tomato sauce 
62 4371 
ABBREVIATIONS: GI: glycemic index; CHO: available carbohydrate; MSKCC: Memorial Sloan Kettering Cancer Center. 
a. For Italy Multicenter, Switzerland, and Milan (2006 - 2009) studies, the same questionnaire was used. For Boston, North Carolina, MSKCC, and Seattle studies, different questionnaires with 
similar high glycemic index food items were used. We, therefore, combined their information in this table.  
b. GI x CHO: product of the (available) carbohydrates content per food serving times its GI value in the food-frequency questionnaire. 
c. Pancakes/waffles item was present in the Boston study only. 
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Supplementary Table 3. Descriptive statistics on glycemic index and glycemic load across study centers and in all the studies combined. 
International Head and Neck Cancer Epidemiology (INHANCE) consortium. 
Study Center Q1 (25th) Median Q3 (75th) 
Glycemic Index    
Overall 71.53 76.25 81.07 
 
   
Boston 79.69 82.74 85.5 
Italy Multicenter    
    Pordenone 70.61 74.77 78.7 
    Milan 70.88 74.56 78.06 
    Latina 72.29 76.19 79.31 
Los Angeles 72.37 77.33 82.52 
MSKCC 76 80.16 83.97 
Milan (2006-2009) 74.64 78.44 81.55 
North Carolina (2002-2006) 69.55 72.97 76.39 
Seattle (1985-1995) 76.96 80.02 83.64 
Switzerland 67.9 75.01 82.94 
    
Glycemic Load    
Overall 141.69 191.73 253.07 
 
   
Boston 169.39 221.98 284.74 
Italy Multicenter    
    Pordenone 171.7 213.63 267.14 
    Milan 146.54 191.72 240.18 
    Latina 165.07 213.3 260.19 
Los Angeles 113.74 161.49 238.64 
MSKCC 90.42 138.24 182.26 
Milan (2006-2009) 167.86 203.88 250.75 
North Carolina (2002-2006) 119.86 163.59 217.67 
Seattle (1985-1995) 119.75 166.65 207.98 
Switzerland 112.37 169.94 245.69 
ABBREVIATIONS: MSKCC: Memorial Sloan Kettering Cancer Center. 
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Supplementary Table 4. Distribution of selected characteristics among controls and cancer cases of head and neck, oral cavity, oropharynx, 
hypopharynx, and larynx. International Head and Neck Cancer Epidemiology (INHANCE) consortium. 
    Controls  (7407), n(%) 
Head and neck cases 
(4081), n(%) 
Oral cavity cases 
(810), n(%) 
Oropharynx cases 
(1172), n(%) 
Hypopharynx cases 
(343), n(%) 
Larynx cases 
(1338), n(%) 
Age (years)        17 to 40 461 (6.2) 152 (3.7) 41 (5.1) 46 (3.9) 2 (0.6) 22 (1.6) 
 40 to 44 434 (5.9) 195 (4.8) 41 (5.1) 63 (5.4) 13 (3.8) 46 (3.4) 
 45 to 49 720 (9.7) 475 (11.6) 93 (11.5) 177 (15.1) 36 (10.5) 111 (8.3) 
 50 to 54 1206 (16.3) 668 (16.4) 130 (16.0) 234 (20.0) 67 (19.5) 170 (12.7) 
 55 to 59 1338 (18.1) 823 (20.2) 161 (19.9) 258 (22.0) 75 (21.9) 257 (19.2) 
 60 to 64 1084 (14.6) 638 (15.6) 123 (15.2) 159 (13.6) 60 (17.5) 242 (18.1) 
 65 to 69 1021 (13.8) 569 (13.9) 105 (13.0) 139 (11.9) 52 (15.2) 231 (17.3) 
 70 to 74 847 (11.4) 391 (9.6) 74 (9.1) 76 (6.5) 28 (8.2) 186 (13.9) 
 75 to 89 294 (4.0) 170 (4.2) 42 (5.2) 20 (1.7) 10 (2.9) 73 (5.5) 
 Missing 2 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Sex       
 Female 2382 (32.2) 874 (21.4) 269 (33.2) 217 (18.5) 57 (16.6) 196 (14.6) 
 Male 5020 (67.8) 3202 (78.5) 538 (66.4) 954 (81.4) 286 (83.4) 1141 (85.3) 
 Missing 5 (0.1) 5 (0.1) 3 (0.4) 1 (0.1) 0 (0.0) 1 (0.1) 
Race       
 Black 340 (4.6) 335 (8.2) 62 (7.7) 81 (6.9) 23 (6.7) 118 (8.8) 
 Others (with Asians) 107 (1.4) 76 (1.9) 9 (1.1) 29 (2.5) 3 (0.9) 15 (1.1) 
 White (with Hispanics) 6917 (93.4) 3653 (89.5) 733 (90.5) 1060 (90.4) 315 (91.8) 1200 (89.7) 
 Missing 43 (0.6) 17 (0.4) 6 (0.7) 2 (0.2) 2 (0.6) 5 (0.4) 
Study center       
 Boston 611 (8.2) 358 (8.8) 76 (9.4) 160 (13.7) 33 (9.6) 64 (4.8) 
 Italy Multicenter       
     Milan 621 (8.4) 193 (4.7) 57 (7.0) 57 (4.9) 24 (7.0) 24 (1.8) 
     Pordenone 1527 (20.6) 880 (21.6) 79 (9.8) 220 (18.8) 105 (30.6) 436 (32.6) 
     Latina 425 (5.7) 95 (2.3) 40 (4.9) 34 (2.9) 7 (2.0) 0 (0.0) 
 Los Angeles 1018 (13.7) 400 (9.8) 49 (6.0) 144 (12.3) 16 (4.7) 83 (6.2) 
 MSKCC 123 (1.7) 106 (2.6) 52 (6.4) 11 (0.9) 10 (2.9) 32 (2.4) 
 Milan (2006-2009) 691 (9.3) 331 (8.1) 79 (9.8) 36 (3.1) 14 (4.1) 203 (15.2) 
 North Carolina (2002-2006) 1120 (15.1) 1057 (25.9) 152 (18.8) 298 (25.4) 47 (13.7) 373 (27.9) 
 Seattle (1985-1995) 394 (5.3) 175 (4.3) 93 (11.5) 74 (6.3) 0 (0.0) 0 (0.0) 
 Switzerland 877 (11.8) 486 (11.9) 133 (16.4) 138 (11.8) 87 (25.4) 123 (9.2) 
Education       
 No education 20 (0.3) 14 (0.3) 3 (0.4) 4 (0.3) 1 (0.3) 5 (0.4) 
 Less than junior high school 2603 (35.1) 1386 (34.0) 221 (27.3) 332 (28.3) 143 (41.7) 592 (44.2) 
 Some high school 803 (10.8) 678 (16.6) 162 (20.0) 185 (15.8) 62 (18.1) 215 (16.1) 
 High school graduate 917 (12.4) 660 (16.2) 133 (16.4) 185 (15.8) 58 (16.9) 197 (14.7) 
 Technical school, some college 1510 (20.4) 748 (18.3) 176 (21.7) 239 (20.4) 44 (12.8) 204 (15.2) 
 More than college graduate 1550 (20.9) 588 (14.4) 114 (14.1) 224 (19.1) 35 (10.2) 123 (9.2) 
  Missing 4 (0.1) 7 (0.2) 1 (0.1) 3 (0.3) 0 (0.0) 2 (0.1) 
ABBREVIATIONS: MSKCC: Memorial Sloan Kettering Cancer Center.     
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Supplementary Table 4. (continued) Distribution of selected characteristics among controls and cancer cases of head and neck, oral cavity, 
oropharynx, hypopharynx, and larynx. International Head and Neck Cancer Epidemiology (INHANCE) consortium. 
   Controls  (7407), n(%) 
Head and neck cases 
(4081), n(%) 
Oral cavity cases 
(810), n(%) 
Oropharynx cases 
(1172), n(%) 
Hypopharynx cases 
(343), n(%) 
Larynx cases 
(1338), n(%) 
Cigarette smoking status        Never 3111 (42.0) 578 (14.2) 137 (16.9) 216 (18.4) 24 (7.0) 80 (6.0) 
 Former 3060 (41.3) 1738 (42.6) 244 (30.1) 523 (44.6) 150 (43.7) 683 (51.0) 
 Current 1210 (16.3) 1749 (42.9) 424 (52.3) 430 (36.7) 169 (49.3) 566 (42.3) 
 Missing 26 (0.4) 16 (0.4) 5 (0.6) 3 (0.3) 0 (0.0) 9 (0.7) 
Cigarette smoking intensity (number of cigarettes/day)      Never smokers 3111 (42.0) 579 (14.2) 137 (16.9) 216 (18.4) 24 (7.0) 81 (6.1) 
 > 0 to 10 1367 (18.5) 460 (11.3) 85 (10.5) 150 (12.8) 29 (8.5) 138 (10.3) 
 > 10 to 20 1791 (24.2) 1493 (36.6) 285 (35.2) 403 (34.4) 124 (36.2) 563 (42.1) 
 > 20 to 30 530 (7.2) 719 (17.6) 137 (16.9) 198 (16.9) 71 (20.7) 250 (18.7) 
 >30 to 40 352 (4.8) 558 (13.7) 110 (13.6) 145 (12.4) 61 (17.8) 204 (15.2) 
 40+ 184 (2.5) 227 (5.6) 45 (5.6) 53 (4.5) 24 (7.0) 88 (6.6) 
 Missing 72 (1.0) 45 (1.1) 11 (1.4) 7 (0.6) 10 (2.9) 14 (1.0) 
Cigarette smoking duration (years)       
 Never smokers 3111 (42.0) 579 (14.2) 137 (16.9) 216 (18.4) 24 (7.0) 81 (6.1) 
 > 0 to 10 560 (7.6) 143 (3.5) 25 (3.1) 62 (5.3) 6 (1.7) 20 (1.5) 
 > 10 to 20 858 (11.6) 263 (6.4) 62 (7.7) 83 (7.1) 20 (5.8) 67 (5.0) 
 > 20 to 30 1062 (14.3) 691 (16.9) 139 (17.2) 222 (18.9) 69 (20.1) 203 (15.2) 
 >30 to 40 978 (13.2) 1173 (28.7) 242 (29.9) 339 (28.9) 114 (33.2) 398 (29.7) 
 40+ 820 (11.1) 1220 (29.9) 200 (24.7) 247 (21.1) 110 (32.1) 565 (42.2) 
 Missing 18 (0.2) 12 (0.3) 5 (0.6) 3 (0.3)  4 (0.3) 
Cigar smoking status       
 Never cigar user 6980 (94.2) 3729 (91.4) 747 (92.2) 1073 (91.6) 318 (92.7) 1219 (91.1) 
 Ever smoked more than 100 402 (5.4) 330 (8.1) 56 (6.9) 95 (8.1) 22 (6.4) 112 (8.4) 
 Missing 25 (0.3) 22 (0.5) 7 (0.9) 4 (0.3) 3 (0.9) 7 (0.5) 
Pipe smoking status       
 Never pipe user 6870 (92.8) 3747 (91.8) 742 (91.6) 1073 (91.6) 316 (92.1) 1235 (92.3) 
 Ever smoked more than 100  508 (6.9) 311 (7.6) 64 (7.9) 97 (8.3) 24 (7.0) 90 (6.7) 
 Missing 29 (0.4) 23 (0.6) 4 (0.5) 2 (0.2) 3 (0.9) 13 (1.0) 
Alcohol drinking intensity (number of drinks/day)      Never drinker 1741 (23.5) 395 (9.7) 91 (11.2) 107 (9.1) 16 (4.7) 114 (8.5) 
 <1 2260 (30.5) 674 (16.5) 154 (19.0) 225 (19.2) 18 (5.2) 172 (12.9) 
 1 to < 3 1898 (25.6) 797 (19.5) 158 (19.5) 233 (19.9) 57 (16.6) 279 (20.9) 
 3 to < 5 818 (11.0) 607 (14.9) 125 (15.4) 146 (12.5) 59 (17.2) 222 (16.6) 
 5+ 689 (9.3) 1605 (39.3) 281 (34.7) 461 (39.3) 193 (56.3) 550 (41.1) 
  Missing 1 (0.0) 3 (0.1) 1 (0.1) 0 (0.0) 0 (0.0) 1 (0.1) 
ABBREVIATIONS: MSKCC: Memorial Sloan Kettering Cancer Center.     
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Supplementary Table 5. Odds ratios (ORs)a and 95% confidence intervals (CIs) of glycemic index and glycemic load on head and neck cancer in 
strata of selected  covariates. International Head and Neck Cancer Epidemiology (INHANCE) consortium. 
    Glycemic Index Glycemic Load 
        II Quartile     III Quartile     IV Quartile Pstudiesc     II Quartile     III Quartile     IV Quartile Pstudiesc 
Age (years)          17 to 54 1.20 (1.00, 1.45) 1.15 (0.97, 1.36) 1.34 (1.10, 1.64) 0.923 1.06 (0.82, 1.37) 1.03 (0.77, 1.37) 0.99 (0.76, 1.30) 0.805 
 55 to 89 0.93 (0.76, 1.14) 0.98 (0.71, 1.35) 1.06 (0.83, 1.36) 0.058 1.00 (0.77, 1.31) 0.89 (0.62, 1.28) 0.95 (0.74, 1.23) 0.023 
 Pstratab  0.676    0.690   
Sex          Female 1.04 (0.81, 1.33) 1.08 (0.84, 1.40) 1.23 (0.96, 1.58) 0.051 0.92 (0.72, 1.18) 0.99 (0.76, 1.28) 1.02 (0.76, 1.37) 0.550 
 Male 1.04 (0.89, 1.21) 1.00 (0.86, 1.16) 1.11 (0.96, 1.29) 0.565 0.93 (0.79, 1.09) 0.85 (0.72, 1.00) 0.87 (0.74, 1.02) 0.598 
 Pstratab  0.277    0.677   
Education         
 <= Junior high school 0.65 (0.37, 1.15) 0.77 (0.54, 1.11) 0.92 (0.53, 1.58) 0.061 0.90 (0.64, 1.26) 0.78 (0.53, 1.14) 0.64 (0.34, 1.17) 0.003 
 <= High school 1.10 (0.81, 1.51) 1.12 (0.77, 1.62) 1.53 (1.04, 2.26) 0.331 1.11 (0.67, 1.84) 0.95 (0.60, 1.51) 1.20 (0.73, 1.96) 0.272 
 >= Some college 1.02 (0.83, 1.25) 1.05 (0.89, 1.26) 1.07 (0.91, 1.27) 0.504 1.09 (0.92, 1.29) 0.95 (0.84, 1.08) 0.90 (0.77, 1.04) 0.970 
 Pstratab  0.991    0.516   
Tobacco smoking status         Never  0.91 (0.70, 1.19) 1.02 (0.78, 1.32) 1.03 (0.79, 1.34) 0.572 1.06 (0.81, 1.38) 0.93 (0.70, 1.24) 0.89 (0.65, 1.22) 0.328 
 Former 1.11 (0.92, 1.34) 1.03 (0.85, 1.25) 1.24 (1.03, 1.49) 0.579 0.97 (0.80, 1.19) 0.92 (0.75, 1.12) 0.98 (0.80, 1.21) 0.708 
 Current 1.01 (0.77, 1.31) 0.99 (0.76, 1.28) 1.10 (0.86, 1.42) 0.356 0.82 (0.63, 1.07) 0.86 (0.66, 1.14) 0.82 (0.62, 1.08) 0.634 
 Pstratab  0.621    0.855   
Cigarette smoking intensity (number of cigarettes/day)       
 Never  0.91 (0.70, 1.19) 1.02 (0.79, 1.33) 1.03 (0.79, 1.34) 0.573 1.07 (0.82, 1.39) 0.93 (0.70, 1.24) 0.89 (0.65, 1.22) 0.312 
 >0 to 20 1.10 (0.92, 1.33) 0.99 (0.82, 1.19) 1.25 (1.04, 1.50) 0.246 0.93 (0.77, 1.12) 0.85 (0.70, 1.03) 0.96 (0.79, 1.18) 0.700 
 >20 0.98 (0.75, 1.28) 1.08 (0.83, 1.40) 1.10 (0.85, 1.42) 0.526 0.90 (0.69, 1.19) 1.00 (0.76, 1.32) 0.81 (0.61, 1.08) 0.465 
 Pstratab  0.830    0.533   
Alcohol drinking intensity          Never/light 1.08 (0.88, 1.34) 1.03 (0.83, 1.28) 1.16 (0.95, 1.43) 0.414 1.14 (0.93, 1.41) 1.00 (0.79, 1.25) 1.04 (0.82, 1.32) 0.779 
 Moderate 1.04 (0.84, 1.29) 1.07 (0.87, 1.32) 1.14 (0.92, 1.41) 0.272 0.89 (0.72, 1.10) 0.85 (0.68, 1.06) 0.90 (0.71, 1.14) 0.495 
 Heavy 1.03 (0.77, 1.38) 1.11 (0.83, 1.49) 1.27 (0.96, 1.69) 0.943 0.75 (0.54, 1.04) 0.86 (0.62, 1.18) 0.79 (0.57, 1.08) 0.988 
 Pstratab  0.623    0.063   
BMI (kg/m2)          Underweight  0.50 (0.18, 1.40) 1.12 (0.50, 2.51) 1.09 (0.25, 4.73) 0.310 0.50 (0.16, 1.54) 0.75 (0.23, 2.37) 0.62 (0.16, 2.36) 0.294 
 Normal 1.04 (0.84, 1.30) 1.13 (0.91, 1.41) 1.22 (1.00, 1.48) 0.630 0.90 (0.72, 1.12) 0.79 (0.63, 1.00) 0.81 (0.64, 1.02) 0.737 
 Overweight/Obese   1.07 (0.77, 1.50) 0.95 (0.56, 1.60) 1.02 (0.78, 1.32) 0.014 0.97 (0.81, 1.16) 0.94 (0.78, 1.13) 0.95 (0.78, 1.15) 0.153 
 Pstratab  0.471    0.472   
Study design         
 Hospital-based controls 1.20 (1.00, 1.45) 1.13 (0.94, 1.36) 1.29 (1.07, 1.54) 0.238 0.96 (0.79, 1.16) 0.95 (0.78, 1.15) 1.00 (0.82, 1.22) 0.261 
 Population-based controls 0.90 (0.74, 1.08) 0.94 (0.79, 1.13) 1.08 (0.91, 1.30) 0.561 0.98 (0.81, 1.18) 0.89 (0.73, 1.09) 0.84 (0.68, 1.04) 0.911 
 Pstratab  0.983    0.672   
Region          Europe 1.20 (1.00, 1.45) 1.10 (0.91, 1.32) 1.29 (1.07, 1.55) 0.384 0.93 (0.77, 1.13) 0.92 (0.76, 1.12) 0.98 (0.81, 1.20) 0.431 
 North America 0.90 (0.75, 1.09) 0.98 (0.82, 1.17) 1.09 (0.91, 1.30) 0.388 1.01 (0.84, 1.22) 0.93 (0.77, 1.13) 0.88 (0.71, 1.08) 0.554 
  Pstratad   0.770       0.432     
a. Adjusted for age, sex, race/ethnicity, study center, education levels, energy intake (without alcohol for glycemic index; without alcohol and carbohydrate for glycemic 
load), cigarette smoking intensity (number of cigarettes per day), cigarette smoking duration, cigar smoking status, pipe smoking status, alcohol drinking intensity (number 
of drinks per day), and the product (interaction) term for cigarette smoking and alcohol drinking, when appropriate.  b. P for heterogeneity across strata. c. P for 
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heterogeneity between study centers. When Pstudies < 0.1 in one of the strata, we consistently reported the stratum-specific mixed-effects estimates for every stratum.  
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